Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Laezza

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Cancers|December 23, 2022
N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma CellsCristina Pagano, Laura Coppola, Giovanna Navarra, et al.
European Journal of Medicinal Chemistry|April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffoldClementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
ACS Omega|April 6, 2026
Gold Nanoparticles Enhance Radiosensitivity in Glioblastoma CellsLaura Coppola, Giovanna Navarra, Giorgio Avilia, et al.
European Journal of Medicinal Chemistry|February 13, 2014
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptorValentina Lucchesi, Teija Parkkari, Juha R Savinainen, et al.
European Journal of Pharmacology|July 23, 2013
PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell linesGiuseppina Gangemi, Patrizia Gazzerro, Donatella Fiore, et al.
European Journal of Medicinal Chemistry|May 4, 2015
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activityClementina Manera, Anna Maria Malfitano, Teija Parkkari, et al.
Journal of Cellular Physiology|October 14, 2016
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary CellsElisabetta Benedetti, Michele d'Angelo, Alessandra Ammazzalorso, et al.
Cancer Biology & Therapy|September 23, 2015
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cellsDonatella Fiore, Maria Chiara Proto, Simona Pisanti, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Cancers|December 23, 2022
N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma CellsCristina Pagano, Laura Coppola, Giovanna Navarra, et al.
European Journal of Medicinal Chemistry|April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffoldClementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
ACS Omega|April 6, 2026
Gold Nanoparticles Enhance Radiosensitivity in Glioblastoma CellsLaura Coppola, Giovanna Navarra, Giorgio Avilia, et al.
European Journal of Medicinal Chemistry|February 13, 2014
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptorValentina Lucchesi, Teija Parkkari, Juha R Savinainen, et al.
European Journal of Pharmacology|July 23, 2013
PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell linesGiuseppina Gangemi, Patrizia Gazzerro, Donatella Fiore, et al.
European Journal of Medicinal Chemistry|May 4, 2015
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activityClementina Manera, Anna Maria Malfitano, Teija Parkkari, et al.
Journal of Cellular Physiology|October 14, 2016
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary CellsElisabetta Benedetti, Michele d'Angelo, Alessandra Ammazzalorso, et al.
Cancer Biology & Therapy|September 23, 2015
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cellsDonatella Fiore, Maria Chiara Proto, Simona Pisanti, et al.
Pageof 10